메뉴 건너뛰기




Volumn 229, Issue 1, 2013, Pages 102-109

Liver involvement in sphingosine 1-phosphate dynamism revealed byadenoviral hepatic overexpression of apolipoprotein M

Author keywords

Apolipoprotein M; Blood cells; HDL; Liver; Sphingosine 1 phosphate

Indexed keywords

ADENOVIRUS VECTOR; APOLIPOPROTEIN M; HIGH DENSITY LIPOPROTEIN; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE;

EID: 84879415868     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.04.024     Document Type: Article
Times cited : (71)

References (30)
  • 1
    • 79955653216 scopus 로고    scopus 로고
    • Clinical review: the evolving role of HDL in the treatment of high-risk patients with cardiovascular disease
    • Brewer H.B. Clinical review: the evolving role of HDL in the treatment of high-risk patients with cardiovascular disease. JClin Endocrinol Metab 2011, 96:1246-1257.
    • (2011) JClin Endocrinol Metab , vol.96 , pp. 1246-1257
    • Brewer, H.B.1
  • 2
    • 77953852336 scopus 로고    scopus 로고
    • Anti-oxidant properties of high-density lipoprotein and atherosclerosis
    • Podrez E.A. Anti-oxidant properties of high-density lipoprotein and atherosclerosis. Clin Exp Pharmacol Physiol 2010, 37:719-725.
    • (2010) Clin Exp Pharmacol Physiol , vol.37 , pp. 719-725
    • Podrez, E.A.1
  • 3
    • 0037162038 scopus 로고    scopus 로고
    • Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator?
    • Okajima F. Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator?. Biochim Biophys Acta 2002, 1582:132-137.
    • (2002) Biochim Biophys Acta , vol.1582 , pp. 132-137
    • Okajima, F.1
  • 4
    • 64849106325 scopus 로고    scopus 로고
    • Sphingosine-1-phosphate: a bioactive lipid that confers high-density lipoprotein with vasculoprotection mediated by nitric oxide and prostacyclin
    • Rodriguez C., Gonzalez-Diez M., Badimon L., et al. Sphingosine-1-phosphate: a bioactive lipid that confers high-density lipoprotein with vasculoprotection mediated by nitric oxide and prostacyclin. Thromb Haemost 2009, 101:665-673.
    • (2009) Thromb Haemost , vol.101 , pp. 665-673
    • Rodriguez, C.1    Gonzalez-Diez, M.2    Badimon, L.3
  • 5
    • 33644916646 scopus 로고    scopus 로고
    • Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular diseases
    • Yatomi Y. Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular diseases. Curr Pharm Des 2006, 12:575-587.
    • (2006) Curr Pharm Des , vol.12 , pp. 575-587
    • Yatomi, Y.1
  • 6
    • 0035943594 scopus 로고    scopus 로고
    • Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells
    • Kimura T., Sato K., Kuwabara A., et al. Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells. JBiol Chem 2001, 276:31780-31785.
    • (2001) JBiol Chem , vol.276 , pp. 31780-31785
    • Kimura, T.1    Sato, K.2    Kuwabara, A.3
  • 7
    • 33846016241 scopus 로고    scopus 로고
    • Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells
    • Kimura T., Tomura H., Mogi C., et al. Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells. JBiol Chem 2006, 281:37457-37467.
    • (2006) JBiol Chem , vol.281 , pp. 37457-37467
    • Kimura, T.1    Tomura, H.2    Mogi, C.3
  • 8
    • 79955677017 scopus 로고    scopus 로고
    • S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease
    • Argraves K.M., Sethi A.A., Gazzolo P.J., et al. S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease. Lipids Health Dis 2011, 10:70.
    • (2011) Lipids Health Dis , vol.10 , pp. 70
    • Argraves, K.M.1    Sethi, A.A.2    Gazzolo, P.J.3
  • 9
    • 78649318696 scopus 로고    scopus 로고
    • Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease
    • Sattler K.J., Elbasan S., Keul P., et al. Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease. Basic Res Cardiol 2010, 105:821-832.
    • (2010) Basic Res Cardiol , vol.105 , pp. 821-832
    • Sattler, K.J.1    Elbasan, S.2    Keul, P.3
  • 10
    • 0029052921 scopus 로고
    • Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets
    • Yatomi Y., Ruan F., Hakomori S., et al. Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood 1995, 86:193-202.
    • (1995) Blood , vol.86 , pp. 193-202
    • Yatomi, Y.1    Ruan, F.2    Hakomori, S.3
  • 11
    • 40749087537 scopus 로고    scopus 로고
    • Plasma sphingosine 1-phosphate metabolism and analysis
    • Yatomi Y. Plasma sphingosine 1-phosphate metabolism and analysis. Biochim Biophys Acta 2008, 1780:606-611.
    • (2008) Biochim Biophys Acta , vol.1780 , pp. 606-611
    • Yatomi, Y.1
  • 12
    • 41449112571 scopus 로고    scopus 로고
    • Vascular endothelium as a contributor of plasma sphingosine 1-phosphate
    • Venkataraman K., Lee Y.M., Michaud J., et al. Vascular endothelium as a contributor of plasma sphingosine 1-phosphate. Circ Res 2008, 102:669-676.
    • (2008) Circ Res , vol.102 , pp. 669-676
    • Venkataraman, K.1    Lee, Y.M.2    Michaud, J.3
  • 13
    • 84859727262 scopus 로고    scopus 로고
    • The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice
    • Fukuhara S., Simmons S., Kawamura S., et al. The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice. JClin Invest 2012, 122:1416-1426.
    • (2012) JClin Invest , vol.122 , pp. 1416-1426
    • Fukuhara, S.1    Simmons, S.2    Kawamura, S.3
  • 14
    • 52449129893 scopus 로고    scopus 로고
    • HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production
    • Tolle M., Pawlak A., Schuchardt M., et al. HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production. Arterioscler Thromb Vasc Biol 2008, 28:1542-1548.
    • (2008) Arterioscler Thromb Vasc Biol , vol.28 , pp. 1542-1548
    • Tolle, M.1    Pawlak, A.2    Schuchardt, M.3
  • 15
    • 0039136346 scopus 로고    scopus 로고
    • Anovel human apolipoprotein (apoM)
    • Xu N., Dahlback B. Anovel human apolipoprotein (apoM). JBiol Chem 1999, 274:31286-31290.
    • (1999) JBiol Chem , vol.274 , pp. 31286-31290
    • Xu, N.1    Dahlback, B.2
  • 16
    • 17644393111 scopus 로고    scopus 로고
    • Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis
    • Wolfrum C., Poy M.N., Stoffel M. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat Med 2005, 11:418-422.
    • (2005) Nat Med , vol.11 , pp. 418-422
    • Wolfrum, C.1    Poy, M.N.2    Stoffel, M.3
  • 17
    • 38349149516 scopus 로고    scopus 로고
    • Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice
    • Christoffersen C., Jauhiainen M., Moser M., et al. Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice. JBiol Chem 2008, 283:1839-1847.
    • (2008) JBiol Chem , vol.283 , pp. 1839-1847
    • Christoffersen, C.1    Jauhiainen, M.2    Moser, M.3
  • 18
    • 79959340773 scopus 로고    scopus 로고
    • Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M
    • Christoffersen C., Obinata H., Kumaraswamy S.B., et al. Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M. Proc Natl Acad Sci U S A 2011, 108:9613-9618.
    • (2011) Proc Natl Acad Sci U S A , vol.108 , pp. 9613-9618
    • Christoffersen, C.1    Obinata, H.2    Kumaraswamy, S.B.3
  • 19
    • 77957324510 scopus 로고    scopus 로고
    • Determination of sphingosine kinase activity in biological samples by liquid chromatography-tandem mass spectrometry
    • Lan T., Bi H., Xu S., et al. Determination of sphingosine kinase activity in biological samples by liquid chromatography-tandem mass spectrometry. Biomed Chromatogr 2010, 24:1075-1083.
    • (2010) Biomed Chromatogr , vol.24 , pp. 1075-1083
    • Lan, T.1    Bi, H.2    Xu, S.3
  • 20
    • 0030054341 scopus 로고    scopus 로고
    • N, N-dimethylsphingosine inhibition of sphingosine kinase and sphingosine 1-phosphate activity in human platelets
    • Yatomi Y., Ruan F., Megidish T., et al. N, N-dimethylsphingosine inhibition of sphingosine kinase and sphingosine 1-phosphate activity in human platelets. Biochemistry 1996, 35:626-633.
    • (1996) Biochemistry , vol.35 , pp. 626-633
    • Yatomi, Y.1    Ruan, F.2    Megidish, T.3
  • 21
    • 23344453368 scopus 로고    scopus 로고
    • Sphingosine 1-phosphate-related metabolism in the blood vessel
    • Aoki S., Yatomi Y., Ohta M., et al. Sphingosine 1-phosphate-related metabolism in the blood vessel. JBiochem 2005, 138:47-55.
    • (2005) JBiochem , vol.138 , pp. 47-55
    • Aoki, S.1    Yatomi, Y.2    Ohta, M.3
  • 22
    • 67650479301 scopus 로고    scopus 로고
    • Anti-atherogenic actions of high-density lipoprotein through sphingosine 1-phosphate receptors and scavenger receptor class B type I
    • Okajima F., Sato K., Kimura T. Anti-atherogenic actions of high-density lipoprotein through sphingosine 1-phosphate receptors and scavenger receptor class B type I. Endocr J 2009, 56:317-334.
    • (2009) Endocr J , vol.56 , pp. 317-334
    • Okajima, F.1    Sato, K.2    Kimura, T.3
  • 23
    • 34247379074 scopus 로고    scopus 로고
    • Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate
    • Pappu R., Schwab S.R., Cornelissen I., et al. Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science 2007, 316:295-298.
    • (2007) Science , vol.316 , pp. 295-298
    • Pappu, R.1    Schwab, S.R.2    Cornelissen, I.3
  • 24
    • 66349139391 scopus 로고    scopus 로고
    • Lipid phosphate phosphatases and signaling
    • Brindley D.N., Pilquil C. Lipid phosphate phosphatases and signaling. JLipid Res 2009, 50(Suppl):S225-S230.
    • (2009) JLipid Res , vol.50 , Issue.SUPPL.
    • Brindley, D.N.1    Pilquil, C.2
  • 25
    • 0037162091 scopus 로고    scopus 로고
    • Roles for lipid phosphate phosphatases in regulation of cellular signaling
    • Sciorra V.A., Morris A.J. Roles for lipid phosphate phosphatases in regulation of cellular signaling. Biochim Biophys Acta 2002, 1582:45-51.
    • (2002) Biochim Biophys Acta , vol.1582 , pp. 45-51
    • Sciorra, V.A.1    Morris, A.J.2
  • 26
    • 70349813797 scopus 로고    scopus 로고
    • Serendipitous fatty acid binding reveals the structural determinants for ligand recognition in apolipoprotein M
    • Sevvana M., Ahnstrom J., Egerer-Sieber C., et al. Serendipitous fatty acid binding reveals the structural determinants for ligand recognition in apolipoprotein M. JMol Biol 2009, 393:920-936.
    • (2009) JMol Biol , vol.393 , pp. 920-936
    • Sevvana, M.1    Ahnstrom, J.2    Egerer-Sieber, C.3
  • 27
    • 58849083220 scopus 로고    scopus 로고
    • The sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors
    • Kawahara A., Nishi T., Hisano Y., et al. The sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors. Science 2009, 323:524-527.
    • (2009) Science , vol.323 , pp. 524-527
    • Kawahara, A.1    Nishi, T.2    Hisano, Y.3
  • 28
    • 3042651483 scopus 로고    scopus 로고
    • Quality control in the apoA-I secretory pathway: deletion of apoA-I helix 6 leads to the formation of cytosolic phospholipid inclusions
    • Bhat S., Zabalawi M., Willingham M.C., et al. Quality control in the apoA-I secretory pathway: deletion of apoA-I helix 6 leads to the formation of cytosolic phospholipid inclusions. JLipid Res 2004, 45:1207-1220.
    • (2004) JLipid Res , vol.45 , pp. 1207-1220
    • Bhat, S.1    Zabalawi, M.2    Willingham, M.C.3
  • 29
    • 0032775582 scopus 로고    scopus 로고
    • Structural organization of mammalian lipid phosphate phosphatases: implications for signal transduction
    • Waggoner D.W., Xu J., Singh I., et al. Structural organization of mammalian lipid phosphate phosphatases: implications for signal transduction. Biochim Biophys Acta 1999, 1439:299-316.
    • (1999) Biochim Biophys Acta , vol.1439 , pp. 299-316
    • Waggoner, D.W.1    Xu, J.2    Singh, I.3
  • 30
    • 77950460108 scopus 로고    scopus 로고
    • Plasma concentration of bioactive lipid mediator sphingosine 1-phosphate is reduced in patients with chronic hepatitis C
    • Ikeda H., Ohkawa R., Watanabe N., et al. Plasma concentration of bioactive lipid mediator sphingosine 1-phosphate is reduced in patients with chronic hepatitis C. Clin Chim Acta 2010, 411:765-770.
    • (2010) Clin Chim Acta , vol.411 , pp. 765-770
    • Ikeda, H.1    Ohkawa, R.2    Watanabe, N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.